THINQ PHARMA-CRO LTD
Overview
THINQ PHARMA-CRO LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering CETIRIZINE HYDROCHLORIDE USP; CIPROFLOXACIN HYDROCHLORIDE USP; FEXOFENADINE HYDROCHLORIDE USP; MECLIZINE HYDROCHLORIDE USP; OXYBUTYNIN CHLORIDE USP; POTASSIUM CHLORIDE USP.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances THINQ PHARMA-CRO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
THINQ PHARMA-CRO LTD holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- SUCRALFATE USPActive2024-07-04
- POTASSIUM CHLORIDE USPActive2023-09-29
- FEXOFENADINE HYDROCHLORIDE USPActive2021-09-04
- OXYBUTYNIN CHLORIDE USPActive2020-06-26
- CIPROFLOXACIN HYDROCHLORIDE USPActive2016-06-27
- MECLIZINE HYDROCHLORIDE USPActive2015-03-31
- CETIRIZINE HYDROCHLORIDE USPActive2015-01-14
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to THINQ PHARMA-CRO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this THINQ PHARMA-CRO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.